How to Evaluate Entry Into a New Regulated Market

Most failed market entries in financial services do not fail because the commercial thesis was wrong. They fail because the firm underestimated what authorisation, ongoing supervision, and cultural fit would demand, and because the board approved a plan built on optimism rather than evidence. Evaluating entry into a new regulated market is a discipline of honest self-assessment as much as opportunity sizing.

Key Executive Takeaways

• Treat regulatory authorisation as a strategic capability test, not a procedural hurdle: if the operating model cannot meet the supervisor's expectations on day one, the commercial case is moot.
• Separate three distinct questions early: is the market attractive, are we the right firm to serve it, and can we sustain the cost of being regulated there over a full cycle.
• The most common failure mode is committing capital before the group has genuinely stress-tested governance, capital, liquidity, and conduct obligations against the target regime.

Start With the Thesis, Not the Jurisdiction

Before anyone drafts a regulatory gap analysis, force clarity on why this market, why now, and why you. A defensible entry thesis names the specific customer segment, the distribution route, the unit economics, and the source of durable advantage. If the answer is that a competitor entered, or that a jurisdiction has a favourable authorisation timeline, stop. Regulatory arbitrage rarely survives supervisory maturity, and boards that approve it tend to inherit the consequences.

Good practice is to write the thesis in one page, share it with the executive committee, and invite challenge before commissioning any external legal or advisory work. This prevents the classic pattern where a firm spends six figures on a feasibility study that no one is willing to kill.

Test Regulatory Fit Against the Real Operating Model

Once the thesis holds, map the target regime honestly against your existing operating model. This is not a compliance checklist exercise. It means asking:

• What are the prudential requirements, and how do they interact with group capital and liquidity planning?
• What conduct and consumer protection obligations apply, and does the product design genuinely meet them, not just technically comply?
• What are the local governance expectations: board composition, senior manager equivalents, local substance, outsourcing rules?
• What is the supervisor's stated appetite for new entrants in this segment, and what have recent authorisation decisions signalled?

Read recent enforcement notices, Dear CEO letters, and supervisory priorities. These tell you what the regulator actually cares about, which is often narrower and sharper than the rulebook suggests.

Cost the Full Regulated Lifecycle

Most entry business cases understate the ongoing cost of being regulated. Authorisation is the cheap part. Build a five-year cost model that includes local senior hires who meet fit and proper standards, second-line functions with genuine independence, regulatory reporting infrastructure, audit, financial crime systems calibrated to local typologies, and the management time absorbed by supervisory engagement. Then add a realistic contingency for remediation, because most firms face at least one significant supervisory finding in the first three years.

If the numbers only work on optimistic assumptions about scale, the market is probably not for you.

Stress-Test the Governance Case

The board approving entry needs to see more than a strategy paper. It needs a governance case that shows how the group will oversee the new entity, how risks will be escalated across borders, and how conflicts between local and group interests will be resolved. Regulators increasingly probe this at authorisation. A weak answer here is often what tips a marginal application into rejection or protracted conditions.

Appoint the proposed accountable senior manager early and involve them in the application design. If you cannot name that person, you are not ready to apply.

What Good Looks Like

A firm that is ready to enter has: a written thesis that has survived internal challenge, a candid gap analysis signed off by the second line, a fully costed five-year model with downside scenarios, named senior individuals accountable for the new business, and a governance framework that a supervisor would recognise as credible on first reading. Anything less, and the decision in front of the board is not whether to enter, but whether to keep investing in becoming ready.

Frequently Asked Questions

How long should a serious pre-application phase take?

For a meaningful new market or licence class, expect nine to eighteen months of preparation before formal engagement with the supervisor, longer if senior hires or systems build are required. Firms that compress this timeline typically pay for it later in conditions, remediation, or withdrawn applications.

When should we engage the target regulator?

Once the thesis, operating model, and governance structure are substantially defined, but before the application is drafted. Early, well-prepared engagement demonstrates seriousness and surfaces supervisory concerns while they can still be addressed. Approaching a regulator with an unformed proposition damages credibility.

How do we decide between organic entry and acquisition?

Acquisition can shorten the authorisation path but transfers legacy conduct, capital, and cultural risk that is often only visible after completion. Organic entry is slower but produces a cleaner operating model. The right answer depends on how much of the acquired firm you would need to rebuild anyway.

What is the single most common reason boards later regret an entry decision?

Underestimating the management bandwidth required to run a regulated business at a distance. The financial cost is usually forecastable. The distraction from the core franchise, and the drag on group-level supervisory relationships, rarely is.